<DOC>
	<DOC>NCT02418650</DOC>
	<brief_summary>A study to investigate absolute bioavailability of ODM-201 and to determine the mass balance and routes of excretion of ODM-201 in healthy volunteers.</brief_summary>
	<brief_title>Mass Balance, Pharmacokinetics, Biotransformation and Bioavailability Study of ODM-201 in Healthy Male Subjects</brief_title>
	<detailed_description>6 healthy male subjects will be enrolled in part 1 and part 2 of the study, respectively</detailed_description>
	<criteria>Key Healthy males Aged 50 to 65 years (inclusive) Normal weight defined as a body mass index (BMI) of &gt;18.5 and &lt;32.0 kg/m2 Weight 55 to 100 kg (inclusive) Adequate method of contraception during the study and for a period of 6 months after study drug administration Key exclusion Criteria: Evidence of clinically significant disease Intake of any medication that could affect the outcome of the study Known hypersensitivity to the active substances or the excipients of the drug or any serious adverse reaction or serious hypersensitivity to any drug or the formulation excipients History of anaphylactic/anaphylactoid reactions Clinically significant abnormal biochemistry, haematology or urinalysis Current or history of any drug or alcohol abuse in the past 2 years Regular alcohol consumption &gt;21 units per week (1 unit = Â½ pint beer, 25 mL of 40% spirit or a 125 mL glass of wine) Current use or use within the last 12 months of nicotine products Positive drugs of abuse test result Positive hepatitis B surface antigen, hepatitis C virus antibody or human immunodeficiency virus results Presence or history of clinically significant allergy requiring treatment</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>volunteers</keyword>
</DOC>